Petrou, P., Kassis, I., Yaghmour, N., Ginzberg, A., & Karussis, D. (2021). A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis.. Frontiers in bioscience, 26 10, 693-706 .
Uccelli, A., Laroni, A., Brundin, L., Clanet, M., Fernández, Ó., Nabavi, S., Muraro, P., Oliveri, R., Radue, E., Sellner, J., Sørensen, P., Sormani, M., Wuerfel, J., Battaglia, M., & Freedman, M. (2019). MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis. Trials, 20.
Petrou, P., Kassis, I., Levin, N., Paul, F., Backner, Y., Benoliel, T., Oertel, F., Scheel, M., Hallimi, M., Yaghmour, N., Hur, T., Ginzberg, A., Levy, Y., Abramsky, O., & Karussis, D. (2020). Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.. Brain : a journal of neurology.
Herberts, C., Kwa, M., & Hermsen, H. (2011). Risk factors in the development of stem cell therapy. Journal of Translational Medicine, 9, 29 – 29.
5.Volarevic, V., Markovic, B., Gazdic, M., Volarević, A., Jovicic, N., Arsenijević, N., Armstrong, L., Djonov, V., Lako, M., & Stojkovic, M. (2018). Ethical and Safety Issues of Stem Cell-Based Therapy. International Journal of Medical Sciences, 15, 36 – 45.
Krampera, M., Pizzolo, G., Aprili, G., & Franchini, M. (2006). Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone, 39(4), 678–683.
Venkatesh, K., & Sen, D. (2017). Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell-Based Therapy for Parkinson’s Disease. Current Stem Cell Research & Therapy, 12(4), 326–347.
Eggenhofer, E., Luk, F., Dahlke, M., & Hoogduijn, M. (2014). The Life and Fate of Mesenchymal Stem Cells. Frontiers in Immunology, 5, Article 148.
Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., & Shi, Y. (2012). Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues. STEM CELLS Translational Medicine, 1(1), 2011–0019.
Volkman, R., & Offen, D. (2017). Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases. STEM CELLS, 35(8), 1867–1880.
Tanna, T., & Sachan, V. (2014). Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Current Stem Cell Research & Therapy, 9(6), 513–521.
Chen, L., Qiu, R., & Xu, Q. (2014). Mesenchymal stem cell therapy for neurodegenerative diseases. Journal of Nanoscience and Nanotechnology, 14(1), 969–975.
Lunn, J. S., Sakowski, S. A., & Feldman, E. L. (2014). Concise review: Stem cell therapies for amyotrophic lateral sclerosis: Recent advances and prospects for the future. Stem Cells, 32(5), 1099–1109.
